h1 IMF Videos From our weekly educational videos with leading myeloma experts to comprehensive news from key medical cancer conferences around the world, IMF videos are your all-access ticket to critical myeloma research, patient education, and guidance. TV Blog Categories All Content About the IMF ASCO/EHA ASH Ask Dr. Durie Black Swan Research Initiative Community Conversations Community Workshops Emerging Therapies Facebook Live Health Equity IMF History IMWG Inspirational Living Well with Myeloma M-POWER Myeloma in a Minute Myeloma Made Simple Myeloma University NLB Webcasts Patient & Family Webinar Q&A Recent News and Developments Treatments Trending Searches in Myeloma Search by text Per page 6122448 Sort Oldest firstNewest firstRelevanceA-ZZ-A ASCO/EHA Jun 4, 2018 Pomalidomide, bortezomib, and low‐dose dexamethasone vs bortezomib and low-dose dex in lenalidomide-exposed patients with relapsed or refractory MM Ask Dr. Durie May 31, 2018 How much can myeloma patients learn from support groups? Ask Dr. Durie May 24, 2018 How should myeloma patients eradicate or reduce diarrhea that may result from Revlimid (lenalidomide) treatment? Ask Dr. Durie Apr 26, 2018 What does it mean for myeloma patients if their Freelite test results show antigen-excess? Ask Dr. Durie Apr 19, 2018 When should a myeloma patient begin treatment? Ask Dr. Durie Mar 15, 2018 What impact do Revlimid (lenalidomide) and Pomalyst (pomalidomide) have on the bone marrow? Pagination First page « First Previous page ‹ Previous … Page 75 Current page 76 Page 77 Page 78 … Next page Next › Last page Last »
